Trade Core Laboratories - CLBus CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
Trading Conditions
| Spread | 0.23 | ||||||||
|
Long position overnight fee
Long position overnight fee
Go to platform | -0.0308% | ||||||||
|
Short position overnight fee
Short position overnight fee
Go to platform | -0.0137% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 20% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
*Information provided by Capital.com
Core Laboratories NV ESG Risk Ratings
High Medium Low Negligible
‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.
Key Stats
| Prev. Close* | 20.01 |
| Open* | 20.42 |
| 1-Year Change* | -15.3% |
| Day's Range* | 20.33 - 20.33 |
| 52 wk Range | 13.19-35.8287 |
| Average Volume (10 days) | 0.40041 |
| Average Volume (3 months) | 9.38362 |
| Market Cap | 979.362 |
| P/E Ratio | 64.5378 |
| Shares Outstanding | 46371300 |
| Revenue | 487.303 |
| EPS | 0.32725 |
| Dividend (Yield %) | 0.18939 |
| Beta | 2.64002 |
| Next Earnings Date | Jan 31, 2023 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Nov 29, 2022 | 20.73 | 0.50 | 2.47% | 20.23 | 20.99 | 20.22 |
| Nov 28, 2022 | 20.01 | -0.07 | -0.35% | 20.08 | 20.75 | 19.99 |
| Nov 25, 2022 | 20.85 | 0.29 | 1.41% | 20.56 | 21.28 | 20.51 |
| Nov 23, 2022 | 20.92 | 0.25 | 1.21% | 20.67 | 21.00 | 20.28 |
| Nov 22, 2022 | 21.09 | 0.50 | 2.43% | 20.59 | 21.38 | 20.38 |
| Nov 21, 2022 | 20.43 | -0.55 | -2.62% | 20.98 | 20.99 | 19.78 |
| Nov 18, 2022 | 21.70 | -0.12 | -0.55% | 21.82 | 21.83 | 21.28 |
| Nov 17, 2022 | 22.28 | 0.88 | 4.11% | 21.40 | 22.47 | 21.36 |
| Nov 16, 2022 | 22.22 | -0.20 | -0.89% | 22.42 | 22.63 | 22.15 |
| Nov 15, 2022 | 22.95 | 0.56 | 2.50% | 22.39 | 23.15 | 21.94 |
| Nov 14, 2022 | 22.38 | -0.15 | -0.67% | 22.53 | 23.49 | 22.25 |
| Nov 11, 2022 | 22.86 | 1.82 | 8.65% | 21.04 | 23.11 | 21.04 |
| Nov 10, 2022 | 20.46 | -0.13 | -0.63% | 20.59 | 20.95 | 20.00 |
| Nov 9, 2022 | 20.18 | -0.02 | -0.10% | 20.20 | 20.71 | 19.93 |
| Nov 8, 2022 | 21.13 | 0.47 | 2.27% | 20.66 | 21.37 | 20.47 |
| Nov 7, 2022 | 20.91 | 0.26 | 1.26% | 20.65 | 21.20 | 20.57 |
| Nov 4, 2022 | 20.67 | 0.13 | 0.63% | 20.54 | 21.61 | 20.32 |
| Nov 3, 2022 | 20.22 | 1.42 | 7.55% | 18.80 | 20.28 | 18.66 |
| Nov 2, 2022 | 18.90 | -0.54 | -2.78% | 19.44 | 19.71 | 18.78 |
| Nov 1, 2022 | 19.58 | -0.09 | -0.46% | 19.67 | 20.20 | 19.25 |
Core Laboratories Events
| Time (UTC) | Country | Event |
|---|---|---|
| No events scheduled | ||
- Annual
- Quarterly
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|---|
| Total revenue | 590.232 | 647.819 | 700.846 | 668.21 | 487.267 | 470.252 |
| Revenue | 590.232 | 647.819 | 700.846 | 668.21 | 487.267 | 470.252 |
| Cost of Revenue, Total | 437.503 | 464.958 | 496.964 | 495.579 | 374.767 | 367.896 |
| Gross Profit | 152.729 | 182.861 | 203.882 | 172.631 | 112.5 | 102.356 |
| Total Operating Expense | 502.781 | 537.851 | 582.224 | 571.526 | 564.072 | 424.99 |
| Selling/General/Admin. Expenses, Total | 39.39 | 47.737 | 62.91 | 48.023 | 34.033 | 44.173 |
| Depreciation / Amortization | 26.288 | 24.524 | 23.087 | 22.605 | 20.867 | 18.516 |
| Interest Expense (Income) - Net Operating | 1.776 | 0.951 | 2.598 | 1.725 | 1.16 | -0.228 |
| Unusual Expense (Income) | -0.618 | 0.799 | -0.455 | -1.737 | 135.268 | -1.439 |
| Other Operating Expenses, Total | -1.558 | -1.118 | -2.88 | 5.331 | -2.023 | -3.928 |
| Operating Income | 87.451 | 109.968 | 118.622 | 96.684 | -76.805 | 45.262 |
| Interest Income (Expense), Net Non-Operating | -11.572 | -10.734 | -13.328 | -14.69 | -14.372 | -9.152 |
| Net Income Before Taxes | 75.879 | 99.234 | 105.294 | 81.994 | -91.177 | 36.11 |
| Net Income After Taxes | 65.024 | 80.985 | 79.847 | 94.284 | -97.073 | 20.219 |
| Minority Interest | 0.036 | 0.029 | -0.263 | -0.134 | -0.14 | -0.492 |
| Net Income Before Extra. Items | 65.06 | 81.014 | 79.584 | 94.15 | -97.213 | 19.727 |
| Total Extraordinary Items | -1.165 | 2.111 | -0.058 | 7.833 | -0.424 | 0 |
| Net Income | 63.895 | 83.125 | 79.526 | 101.983 | -97.637 | 19.727 |
| Income Available to Common Excl. Extra. Items | 65.06 | 81.014 | 79.584 | 94.15 | -97.213 | 19.727 |
| Income Available to Common Incl. Extra. Items | 63.895 | 83.125 | 79.526 | 101.983 | -97.637 | 19.727 |
| Diluted Net Income | 63.895 | 83.125 | 79.526 | 101.983 | -97.637 | 19.727 |
| Diluted Weighted Average Shares | 43.67 | 44.264 | 44.474 | 44.646 | 44.477 | 46.69 |
| Diluted EPS Excluding Extraordinary Items | 1.48981 | 1.83025 | 1.78945 | 2.10881 | -2.18569 | 0.42251 |
| Dividends per Share - Common Stock Primary Issue | 2.2 | 2.2 | 2.2 | 2.2 | 0.28 | 0.04 |
| Diluted Normalized EPS | 1.47768 | 1.84498 | 1.78169 | 2.08352 | -0.20885 | 0.40525 |
| Q1 2021 | Q2 2021 | Q3 2021 | Q4 2021 | Q1 2022 | |
|---|---|---|---|---|---|
| Total revenue | 108.383 | 118.745 | 117.985 | 125.139 | 115.3 |
| Revenue | 108.383 | 118.745 | 117.985 | 125.139 | 115.3 |
| Cost of Revenue, Total | 84.15 | 93.841 | 92.918 | 96.987 | 96.952 |
| Gross Profit | 24.233 | 24.904 | 25.067 | 28.152 | 18.348 |
| Total Operating Expense | 96.761 | 105.945 | 111.345 | 110.939 | 115.691 |
| Selling/General/Admin. Expenses, Total | 8.461 | 9.67 | 15.115 | 10.927 | 12.545 |
| Depreciation / Amortization | 4.871 | 4.751 | 4.496 | 4.398 | 4.557 |
| Interest Expense (Income) - Net Operating | -0.408 | 0.352 | -0.14 | -0.032 | -0.417 |
| Unusual Expense (Income) | -0.072 | -1.059 | -0.231 | -0.077 | 3.175 |
| Other Operating Expenses, Total | -0.241 | -1.61 | -0.813 | -1.264 | -1.121 |
| Operating Income | 11.622 | 12.8 | 6.64 | 14.2 | -0.391 |
| Interest Income (Expense), Net Non-Operating | -1.363 | -2.53 | -2.669 | -2.59 | -2.644 |
| Net Income Before Taxes | 10.259 | 10.27 | 3.971 | 11.61 | -3.035 |
| Net Income After Taxes | 8.207 | 8.217 | 1.009 | 2.787 | -1.839 |
| Minority Interest | -0.102 | -0.157 | -0.135 | -0.099 | -0.049 |
| Net Income Before Extra. Items | 8.105 | 8.06 | 0.874 | 2.688 | -1.888 |
| Total Extraordinary Items | 0 | 0 | 0 | 0 | |
| Net Income | 8.105 | 8.06 | 0.874 | 2.688 | -1.888 |
| Income Available to Common Excl. Extra. Items | 8.105 | 8.06 | 0.874 | 2.688 | -1.888 |
| Income Available to Common Incl. Extra. Items | 8.105 | 8.06 | 0.874 | 2.688 | -1.888 |
| Diluted Net Income | 8.105 | 8.06 | 0.874 | 2.688 | -1.888 |
| Diluted Weighted Average Shares | 45.964 | 47.103 | 47.125 | 46.261 | 46.298 |
| Diluted EPS Excluding Extraordinary Items | 0.17633 | 0.17111 | 0.01855 | 0.05811 | -0.04078 |
| Dividends per Share - Common Stock Primary Issue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Diluted Normalized EPS | 0.17508 | 0.15313 | 0.01536 | 0.05702 | 0.0038 |
- Annual
- Quarterly
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|---|
| Total Current Assets | 186.461 | 207.427 | 230.977 | 221.237 | 165.848 | 189.055 |
| Cash and Short Term Investments | 14.764 | 14.4 | 13.116 | 11.092 | 13.806 | 17.703 |
| Cash & Equivalents | 14.764 | 14.4 | 13.116 | 11.092 | 13.806 | 17.703 |
| Total Receivables, Net | 120.755 | 140.605 | 143.15 | 138.106 | 92.867 | 106.741 |
| Accounts Receivable - Trade, Net | 114.329 | 133.097 | 129.157 | 131.579 | 83.192 | 96.83 |
| Total Inventory | 33.72 | 33.317 | 45.664 | 50.163 | 38.151 | 45.443 |
| Prepaid Expenses | 10.711 | 12.592 | 15.351 | 15.951 | 14.797 | 14.059 |
| Other Current Assets, Total | 6.511 | 6.513 | 13.696 | 5.925 | 6.227 | 5.109 |
| Total Assets | 573.052 | 584.812 | 648.827 | 774.673 | 568.579 | 580.853 |
| Property/Plant/Equipment, Total - Net | 129.882 | 123.098 | 122.917 | 199.203 | 181.678 | 172.339 |
| Property/Plant/Equipment, Total - Gross | 379.147 | 400.174 | 481.39 | 475.656 | 478.8 | |
| Accumulated Depreciation, Total | -249.265 | -277.257 | -282.187 | -293.978 | -306.461 | |
| Goodwill, Net | 179.044 | 179.044 | 219.412 | 213.425 | 99.445 | 99.445 |
| Intangibles, Net | 9.936 | 9.396 | 13.054 | 17.45 | 8.583 | 8.139 |
| Long Term Investments | 3.224 | 3.76 | ||||
| Other Long Term Assets, Total | 64.505 | 65.847 | 58.707 | 123.358 | 113.025 | 111.875 |
| Total Current Liabilities | 104.023 | 100.576 | 102.547 | 111.594 | 89.75 | 90.782 |
| Accounts Payable | 33.72 | 41.697 | 41.155 | 35.611 | 23.028 | 29.726 |
| Accrued Expenses | 25.227 | 36.2 | 30.037 | 46.896 | 44.519 | 39.106 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities, Total | 45.076 | 22.679 | 31.355 | 29.087 | 22.203 | 21.95 |
| Total Liabilities | 421.698 | 439.968 | 492.068 | 596.808 | 497.066 | 424.404 |
| Total Long Term Debt | 216.488 | 226.989 | 289.77 | 305.283 | 259.433 | 188.636 |
| Long Term Debt | 216.488 | 226.989 | 289.77 | 305.283 | 259.433 | 188.636 |
| Deferred Income Tax | 6.277 | 5.323 | 7.634 | 26.284 | 20.585 | 24.336 |
| Minority Interest | 3.943 | 3.888 | 4.141 | 4.275 | 4.06 | 4.552 |
| Other Liabilities, Total | 90.967 | 103.192 | 87.976 | 149.372 | 123.238 | 116.098 |
| Total Equity | 151.354 | 144.844 | 156.759 | 177.865 | 71.513 | 156.449 |
| Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | ||
| Common Stock | 1.148 | 1.148 | 1.148 | 1.148 | 1.148 | 1.188 |
| Additional Paid-In Capital | 52.85 | 54.463 | 57.438 | 51.872 | 41.184 | 101.12 |
| Retained Earnings (Accumulated Deficit) | 187.957 | 173.855 | 156.13 | 160.539 | 50.456 | 68.349 |
| Treasury Stock - Common | -80.773 | -76.269 | -52.501 | -29.364 | -14.075 | -4.075 |
| Unrealized Gain (Loss) | -9.769 | -8.703 | -6.243 | -5.64 | -1.825 | -4.538 |
| Other Equity, Total | -0.059 | 0.35 | 0.787 | -0.69 | -5.375 | -5.595 |
| Total Liabilities & Shareholders’ Equity | 573.052 | 584.812 | 648.827 | 774.673 | 568.579 | 580.853 |
| Total Common Shares Outstanding | 44.1513 | 44.1842 | 44.3168 | 44.4656 | 44.5728 | 46.3494 |
| Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
|---|---|---|---|---|---|
| Total Current Assets | 185.817 | 201.149 | 187.245 | 189.055 | 202.192 |
| Cash and Short Term Investments | 27.806 | 33.617 | 19.05 | 17.703 | 22.037 |
| Cash & Equivalents | 27.806 | 33.617 | 19.05 | 17.703 | 22.037 |
| Total Receivables, Net | 99.941 | 110.168 | 107.77 | 106.741 | 113.54 |
| Accounts Receivable - Trade, Net | 86.567 | 93.217 | 95.297 | 96.83 | 98.9 |
| Total Inventory | 39.117 | 38.946 | 44.056 | 45.443 | 48.224 |
| Prepaid Expenses | 13.107 | 12.231 | 11.022 | 14.059 | 13.611 |
| Other Current Assets, Total | 5.846 | 6.187 | 5.347 | 5.109 | 4.78 |
| Total Assets | 584.446 | 598.425 | 586.279 | 580.853 | 584.918 |
| Property/Plant/Equipment, Total - Net | 183.786 | 178.88 | 178.115 | 172.339 | 170.094 |
| Goodwill, Net | 99.445 | 99.445 | 99.445 | 99.445 | 99.445 |
| Intangibles, Net | 8.423 | 8.317 | 8.246 | 8.139 | 7.979 |
| Other Long Term Assets, Total | 106.975 | 110.634 | 113.228 | 111.875 | 105.208 |
| Total Current Liabilities | 85.533 | 90.854 | 92.953 | 90.782 | 99.762 |
| Accounts Payable | 25.5 | 30.383 | 35.015 | 29.726 | 34.405 |
| Accrued Expenses | 39.917 | 39.857 | 39.536 | 39.106 | 43.929 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities, Total | 20.116 | 20.614 | 18.402 | 21.95 | 21.428 |
| Total Liabilities | 442.562 | 448.4 | 429.718 | 424.404 | 423.133 |
| Total Long Term Debt | 208.166 | 208.305 | 188.463 | 188.636 | 189.807 |
| Long Term Debt | 208.166 | 208.305 | 188.463 | 188.636 | 189.807 |
| Deferred Income Tax | 20.48 | 20.677 | 23.837 | 24.336 | 23.27 |
| Minority Interest | 4.162 | 4.319 | 4.453 | 4.552 | 4.601 |
| Other Liabilities, Total | 124.221 | 124.245 | 120.012 | 116.098 | 105.693 |
| Total Equity | 141.884 | 150.025 | 156.561 | 156.449 | 161.785 |
| Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | |
| Common Stock | 1.188 | 1.188 | 1.188 | 1.188 | 1.188 |
| Additional Paid-In Capital | 103.358 | 98.255 | 106.027 | 101.12 | 107.088 |
| Retained Earnings (Accumulated Deficit) | 58.115 | 65.712 | 66.123 | 68.349 | 65.998 |
| Treasury Stock - Common | -12.916 | -4.992 | -7.084 | -4.075 | -5.736 |
| Unrealized Gain (Loss) | -2.486 | -4.763 | -4.318 | -4.538 | -1.158 |
| Other Equity, Total | -5.375 | -5.375 | -5.375 | -5.595 | -5.595 |
| Total Liabilities & Shareholders’ Equity | 584.446 | 598.425 | 586.279 | 580.853 | 584.918 |
| Total Common Shares Outstanding | 46.2405 | 46.3255 | 46.26 | 46.3494 | 46.2837 |
- Annual
- Quarterly
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|---|
| Net income/Starting Line | 65.024 | 80.985 | 79.847 | 94.284 | -97.073 | 20.219 |
| Cash From Operating Activities | 131.887 | 124.271 | 111.827 | 89.527 | 57.868 | 36.579 |
| Cash From Operating Activities | 26.872 | 24.524 | 23.087 | 22.605 | 20.867 | 18.516 |
| Deferred Taxes | -14.385 | 9.015 | 1.832 | -36.345 | -12.216 | 6.012 |
| Non-Cash Items | 19.174 | 18.232 | 36.052 | 16.69 | 140.351 | 12.395 |
| Cash Taxes Paid | 12.181 | 24.314 | 31.928 | 13.804 | 21.325 | 9.066 |
| Cash Interest Paid | 11.248 | 10.527 | 11.499 | 13.631 | 11.669 | 10.477 |
| Changes in Working Capital | 35.202 | -8.485 | -28.991 | -7.707 | 5.939 | -20.563 |
| Cash From Investing Activities | -14.721 | -20.557 | -70.639 | -5.677 | 7.851 | -10.223 |
| Capital Expenditures | -11.704 | -19.154 | -22.931 | -22.269 | -11.88 | -13.539 |
| Other Investing Cash Flow Items, Total | -3.017 | -1.403 | -47.708 | 16.592 | 19.731 | 3.316 |
| Cash From Financing Activities | -124.896 | -104.078 | -42.472 | -85.874 | -63.005 | -22.459 |
| Financing Cash Flow Items | -2.548 | -0.026 | -1.77 | 0.008 | -1.766 | -1.369 |
| Total Cash Dividends Paid | -95.145 | -97.143 | -97.251 | -97.574 | -12.446 | -1.834 |
| Issuance (Retirement) of Stock, Net | 190.041 | -16.909 | -7.451 | -3.308 | -2.793 | 51.744 |
| Issuance (Retirement) of Debt, Net | -217.244 | 10 | 64 | 15 | -46 | -71 |
| Net Change in Cash | -7.73 | -0.364 | -1.284 | -2.024 | 2.714 | 3.897 |
| Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
|---|---|---|---|---|---|
| Net income/Starting Line | 8.207 | 16.424 | 17.432 | 20.219 | -1.839 |
| Cash From Operating Activities | 7.987 | 17.473 | 29.425 | 36.579 | 5.29 |
| Cash From Operating Activities | 4.871 | 9.622 | 14.118 | 18.516 | 4.557 |
| Deferred Taxes | 4.704 | 2.732 | 3.058 | 6.012 | 1.698 |
| Non-Cash Items | 4.269 | 7.405 | 11.707 | 12.395 | 8.529 |
| Cash Taxes Paid | 1.429 | 5.069 | 7.27 | 9.066 | 2.691 |
| Cash Interest Paid | 3.739 | 5.489 | 8.841 | 10.477 | 2.508 |
| Changes in Working Capital | -14.064 | -18.71 | -16.89 | -20.563 | -7.655 |
| Cash From Investing Activities | -1.07 | -3.378 | -6.529 | -10.223 | 0.428 |
| Capital Expenditures | -2.772 | -5.657 | -8.789 | -13.539 | -2.297 |
| Other Investing Cash Flow Items, Total | 1.702 | 2.279 | 2.26 | 3.316 | 2.725 |
| Cash From Financing Activities | 7.083 | 5.716 | -17.652 | -22.459 | -1.384 |
| Financing Cash Flow Items | -0.439 | -0.483 | -1.369 | -1.369 | -0.001 |
| Total Cash Dividends Paid | -0.446 | -0.909 | -1.372 | -1.834 | -0.463 |
| Issuance (Retirement) of Stock, Net | 58.968 | 58.108 | 56.089 | 51.744 | -1.92 |
| Issuance (Retirement) of Debt, Net | -51 | -51 | -71 | -71 | 1 |
| Net Change in Cash | 14 | 19.811 | 5.244 | 3.897 | 4.334 |
Why choose Capital.com? Our numbers speak for themselves.
Capital.com Group 475000+
Traders
71000+
Active clients monthly
$51000000+
Monthly investing volume
$30000000+
Try now Withdrawn each month
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
Trade commission
0
- 1:1
- 2:1
- 5:1
- 10:1
- 20:1
Leverage
20:1
- 20
- 100
- 500
- 1000
- 10000
Investment
Trade size (Leverage x Investement):
Open
Close
Short Long
Core Laboratories Company profile
About Core Laboratories N.V.
Core Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples. It provides analytical and field services to characterize properties of crude oil and petroleum products to the oil and gas industry. The Production Enhancement segment includes products and services relating to reservoir well completions, perforations, stimulations and production. It provides integrated diagnostic services to evaluate the effectiveness of well completions. The Reservoir Management segment combines and integrates information from reservoir description and production enhancement services to increase production and recovery of oil and gas from its clients' reservoirs.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Core Laboratories N.V. revenues decreased 3% to $470.3M. Net income before extraordinary items totaled $19.7M vs. loss of $97.2M. Revenues reflect Reservoir Description segment decrease of 12% to $313.6M, United States segment decrease of 7% to $148.2M, Other Countries segment decrease of 2% to $322.1M. Net Income reflects Production Enhancement segment income totaling $15.2M vs. loss of $133.4M.
Equity composition
Common Stock EUR.02 Par 3/11, 200M auth., 49,739,912 issd., less 4,164,536 shs. in Treas. @ $261.4M. Insiders own 1.35%. IPO 9/95,2.8M shs @ $12 by Jefferies. PO 11/97, 300.8M. shs(1.4M by Co.) @ $36 by BTAB. 12/97, 2-for-1 stock split. FY'02-03 fincls. & '03 Qs are restated for discont. ops. 07/10, 2-for-1 stock split.
| Industry: | Oil Related Services and Equipment (NEC) |
Van Heuven Goedhartlaan 7 B
AMSTELVEEN
NOORD-HOLLAND 1181 LE
NL
Income Statement
News
BYD eyes push into North America: EV maker to launch Mexico sales next year
BYD continues on a global expansion, beats Tesla’s growth rate
12:16, 30 November 2022
LBLOCK goes bullish after launch of new Lucky Block Casino and Sportsbook
LBlock's crypto casino and betting platform will accept nine cryptocurrencies including Bitcoin and Ethereum
12:13, 30 November 2022
SEC v Ripple: ‘Regardless of decision, the company will go on’, says head of public policy Susan Friedman
2022 ‘has been a great year for Ripple’, according to Friedman
11:55, 30 November 2022
HSBC sells Canada Unit to RBC for $10bn: Will it pass regulatory scrutiny?
RBC deal for HSBC’s Canada business makes sense but regulator may object
10:40, 30 November 2022
What is Step App? Move-to-earn tech builds Web 3.0 excitement ahead of Tokyo launch
Step App is looking to become the go-to crypto fitness app after its launch this week
10:21, 30 November 2022People also watch
Still looking for a broker you can trust?
Join the 475.000+ traders worldwide that chose to trade with Capital.com